Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. May 21, 2021; 27(19): 2353-2365
Published online May 21, 2021. doi: 10.3748/wjg.v27.i19.2353
Table 1 Demographic and clinical characteristics of patients with Crohn’s disease according to the presence of acute severe lower gastrointestinal bleeding

Bleeding group (n = 75)
Non-bleeding group (n = 1359)
P value
Age at diagnosis, years (median, IQR)23.6 (18.9-31.9)23.2 (18.6-33.5)0.952
Sex, male, n (%)63 (84.0)1000 (73.6)0.045
Disease location at diagnosis, n (%)0.002
Ileum34 (45.3)377 (27.7)
Colon1 (1.3)81 (6.0)
Ileocolon40 (53.4)901 (66.3)
Upper GI modifier at diagnosis, n (%)15 (20)355 (26.1)0.238
Disease behavior at diagnosis, n (%)0.157
Non-stricturing, non-penetrating59 (78.6)1012 (74.5)
Stricturing 11 (14.7)155 (11.4)
Penetrating5 (6.7)192 (14.1)
Perianal modifier at diagnosis, n (%)32 (42.7)686 (50.5)0.204
Smoking status at diagnosis, n (%)0.540
Never smokers51 (68.0)874 (64.3)
Ex-smokers3 (4.0)99 (7.3)
Current smokers21 (28.0)386 (28.4)
Early use of medications, n (%)
Corticosteroids21 (28.0)399 (29.4)0.840
Thiopurines10 (13.3)649 (47.8)< 0.001
Anti-TNF agents1 (1.3)43 (3.2)0.560